Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Alx Oncology Holdings Inc (ALXO) since 2020 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Alx Oncology Holdings Inc. Table 2 shows the detailed insider transactions. This company's CIK number is 1810182.
Total stock buying since 2020: $86,505,171.
Total stock sales since 2020: $41,579,698.
Total stock option exercises since 2020: $1,001,058.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2025 | 75,000 | $58,425 | 12,242 | $11,480 | 0 | $0 |
| 2024 | 42,000 | $148,746 | 165,810 | $1,919,834 | 85,846 | $84,987 |
| 2023 | 0 | $0 | 22,583 | $229,587 | 12,829 | $46,184 |
| 2022 | 0 | $0 | 6,224 | $68,898 | 85,628 | $269,004 |
| 2021 | 0 | $0 | 971,934 | $39,349,899 | 186,680 | $600,883 |
| 2020 | 4,482,000 | $86,298,000 | 0 | $0 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2025-08 | 75,000 | $58,425 | 2,993 | $1,915 | 0 | $0 |
| 2025-07 | 0 | $0 | 2,011 | $904 | 0 | $0 |
| 2025-06 | 0 | $0 | 1,532 | $658 | 0 | $0 |
| 2025-02 | 0 | $0 | 3,485 | $4,006 | 0 | $0 |
| 2025-01 | 0 | $0 | 2,221 | $3,997 | 0 | $0 |
| 2024-12 | 30,000 | $46,410 | 0 | $0 | 0 | $0 |
| 2024-08 | 0 | $0 | 3,866 | $9,973 | 0 | $0 |
| 2024-07 | 0 | $0 | 37,227 | $257,738 | 20,000 | $19,800 |
| 2024-06 | 12,000 | $102,336 | 20,000 | $168,660 | 20,000 | $19,800 |
| 2024-05 | 0 | $0 | 32,000 | $513,268 | 20,000 | $19,800 |
| 2024-04 | 0 | $0 | 70,000 | $933,239 | 25,846 | $25,587 |
| 2024-01 | 0 | $0 | 2,717 | $36,956 | 0 | $0 |
| 2023-12 | 0 | $0 | 9,072 | $136,442 | 0 | $0 |
| 2023-07 | 0 | $0 | 7,345 | $47,889 | 0 | $0 |
| 2023-06 | 0 | $0 | 6,166 | $45,256 | 12,829 | $46,184 |
| 2022-12 | 0 | $0 | 6,224 | $68,898 | 46,474 | $167,306 |
| 2022-02 | 0 | $0 | 0 | $0 | 39,154 | $101,698 |
| 2021-12 | 0 | $0 | 665,041 | $19,847,994 | 23,852 | $34,585 |
| 2021-11 | 0 | $0 | 14,884 | $547,314 | 30,000 | $122,400 |
| 2021-10 | 0 | $0 | 64,716 | $3,599,009 | 7,229 | $29,494 |
| 2021-09 | 0 | $0 | 36,858 | $2,841,582 | 12,771 | $52,105 |
| 2021-08 | 0 | $0 | 94,087 | $6,658,062 | 70,000 | $285,600 |
| 2021-07 | 0 | $0 | 24,087 | $1,316,717 | 0 | $0 |
| 2021-06 | 0 | $0 | 16,700 | $976,766 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-08-18 | Shantharam Harish (Chief Financial Officer) | Buy | 75,000 | .78 | 58,425 |
| 2025-08-15 | Pinto Shelly (SVP, FINANCE AND CAO) | Sale | 611 | .64 | 391 |
| 2025-08-15 | Lettmann Jason (CHIEF EXECUTIVE OFFICER) | Sale | 2,382 | .64 | 1,524 |
| 2025-07-07 | Pinto Shelly (SVP, FINANCE AND CAO) | Sale | 2,011 | .45 | 904 |
| 2025-06-30 | Pinto Shelly (SVP, FINANCE AND CAO) | Sale | 1,532 | .43 | 658 |
| 2025-02-19 | Pons Jaume (PRESIDENT & CSO) | Sale | 1,326 | 1.15 | 1,524 |
| 2025-02-19 | Lettmann Jason (CHIEF EXECUTIVE OFFICER) | Sale | 2,159 | 1.15 | 2,482 |
| 2025-01-06 | Pinto Shelly (Interim CFO) | Sale | 2,221 | 1.80 | 3,997 |
| 2024-12-02 | Hemrajani Rekha | Buy | 30,000 | 1.55 | 46,410 |
| 2024-08-14 | Pinto Shelly (SVP, FINANCE AND CAO) | Sale | 564 | 2.58 | 1,455 |
| 2024-08-14 | Randolph Sophia (CHIEF MEDICAL OFFICER) | Sale | 1,365 | 2.58 | 3,521 |
| 2024-08-14 | Pons Jaume (PRESIDENT & CSO) | Sale | 1,937 | 2.58 | 4,997 |
| 2024-07-11 | Pons Jaume (PRESIDENT & CSO) | Sale | 20,000 | 7.90 | 158,080 |
| 2024-07-11 | Pons Jaume (PRESIDENT & CSO) | Option Ex | 20,000 | .99 | 19,800 |
| 2024-07-05 | Pinto Shelly (SVP, FINANCE AND CAO) | Sale | 1,823 | 5.50 | 10,024 |
| 2024-07-01 | Pinto Shelly (SVP, FINANCE AND CAO) | Sale | 1,373 | 5.82 | 7,989 |
| 2024-07-01 | Randolph Sophia (CHIEF MEDICAL OFFICER) | Sale | 3,273 | 5.82 | 19,045 |
| 2024-07-01 | Pons Jaume (PRESIDENT & CSO) | Sale | 10,758 | 5.82 | 62,600 |
| 2024-06-13 | Garcia Peter S (CHIEF FINANCIAL OFFICER) | Buy | 12,000 | 8.53 | 102,336 |
| 2024-06-04 | Pons Jaume (PRESIDENT & CSO) | Sale | 20,000 | 8.43 | 168,660 |
| 2024-06-04 | Pons Jaume (PRESIDENT & CSO) | Option Ex | 20,000 | .99 | 19,800 |
| 2024-05-13 | Randolph Sophia (CHIEF MEDICAL OFFICER) | Sale | 12,000 | 16.24 | 194,928 |
| 2024-05-06 | Pons Jaume (PRESIDENT & CSO) | Sale | 20,000 | 15.92 | 318,340 |
| 2024-05-06 | Pons Jaume (PRESIDENT & CSO) | Option Ex | 20,000 | .99 | 19,800 |
| 2024-04-16 | Pons Jaume (PRESIDENT & CSO) | Sale | 50,000 | 14.20 | 710,200 |
| 2024-04-16 | Pons Jaume (PRESIDENT & CSO) | Option Ex | 25,846 | .99 | 25,587 |
| 2024-04-04 | Pons Jaume (PRESIDENT & CSO) | Sale | 20,000 | 11.15 | 223,039 |
| 2024-01-04 | Pinto Shelly (SVP, Finance and CAO) | Sale | 2,717 | 13.60 | 36,956 |
| 2023-12-29 | Pons Jaume (President & CSO) | Sale | 7,179 | 15.04 | 107,972 |
| 2023-12-29 | Garcia Peter S (Chief Financial Officer) | Sale | 1,893 | 15.04 | 28,470 |
| 2023-07-06 | Pinto Shelly (VP, Finance and CAO) | Sale | 7,345 | 6.52 | 47,889 |
| 2023-06-30 | Pinto Shelly (VP, Finance and CAO) | Sale | 466 | 7.34 | 3,420 |
| 2023-06-30 | Randolph Sophia (Chief Medical Officer) | Sale | 1,605 | 7.34 | 11,780 |
| 2023-06-30 | Pons Jaume (President & CEO) | Sale | 3,208 | 7.34 | 23,546 |
| 2023-06-30 | Garcia Peter S (Chief Financial Officer) | Sale | 887 | 7.34 | 6,510 |
| 2023-06-09 | Randolph Sophia (Chief Medical Officer) | Option Ex | 12,829 | 3.60 | 46,184 |
| 2022-12-29 | Pinto Shelly (VP, Finance and CAO) | Sale | 482 | 11.07 | 5,335 |
| 2022-12-29 | Randolph Sophia (Chief Medical Officer) | Sale | 1,617 | 11.07 | 17,900 |
| 2022-12-29 | Pons Jaume (President & CEO) | Sale | 3,232 | 11.07 | 35,778 |
| 2022-12-29 | Garcia Peter S (Chief Financial Officer) | Sale | 893 | 11.07 | 9,885 |
| 2022-12-16 | Randolph Sophia (Chief Medical Officer) | Option Ex | 46,474 | 3.60 | 167,306 |
| 2022-02-07 | Garcia Peter S (Chief Financial Officer) | Option Ex | 15,000 | 4.45 | 66,675 |
| 2022-02-03 | Pons Jaume (President & CEO) | Option Ex | 24,154 | 1.45 | 35,023 |
| 2021-12-15 | Randolph Sophia (Chief Medical Officer) | Option Ex | 23,852 | 1.45 | 34,585 |
| 2021-12-13 | Lettmann Jason (Director) | Sale | 325,377 | 27.91 | 9,081,272 |
| 2021-12-13 | Plain Henry A Jr (10% Owner) | Sale | 48,390 | 27.91 | 1,350,564 |
| 2021-12-10 | Lettmann Jason (Director) | Sale | 26,274 | 31.49 | 827,447 |
| 2021-12-10 | Plain Henry A Jr (10% Owner) | Sale | 26,274 | 31.49 | 827,447 |
| 2021-12-09 | Lettmann Jason (Director) | Sale | 76,905 | 31.96 | 2,457,653 |
| 2021-12-09 | Plain Henry A Jr (10% Owner) | Sale | 76,905 | 31.96 | 2,457,653 |
| 2021-12-08 | Lettmann Jason (Director) | Sale | 42,458 | 33.52 | 1,422,979 |
| 2021-12-08 | Plain Henry A Jr (10% Owner) | Sale | 42,458 | 33.52 | 1,422,979 |
| 2021-11-22 | Randolph Sophia (Chief Medical Officer) | Sale | 14,884 | 36.77 | 547,314 |
| 2021-11-22 | Randolph Sophia (Chief Medical Officer) | Option Ex | 30,000 | 4.08 | 122,400 |
| 2021-10-19 | Pons Jaume (President & CEO) | Sale | 33,400 | 54.64 | 1,825,108 |
| 2021-10-18 | Garcia Peter S (Chief Financial Officer) | Sale | 7,229 | 56.75 | 410,216 |
| 2021-10-18 | Garcia Peter S (Chief Financial Officer) | Option Ex | 7,229 | 4.08 | 29,494 |
| 2021-10-11 | Randolph Sophia (Chief Medical Officer) | Sale | 7,387 | 61.07 | 451,131 |
| 2021-09-20 | Pons Jaume (President & CEO) | Sale | 16,700 | 75.03 | 1,252,984 |
| 2021-09-17 | Garcia Peter S (Chief Financial Officer) | Sale | 11,345 | 79.47 | 901,530 |
| 2021-09-17 | Garcia Peter S (Chief Financial Officer) | Option Ex | 11,345 | 4.08 | 46,287 |
| 2021-09-16 | Garcia Peter S (Chief Financial Officer) | Sale | 1,426 | 80.43 | 114,694 |
| 2021-09-16 | Garcia Peter S (Chief Financial Officer) | Option Ex | 1,426 | 4.08 | 5,818 |
| 2021-09-10 | Randolph Sophia (Chief Medical Officer) | Sale | 7,387 | 77.48 | 572,374 |
| 2021-08-23 | Garcia Peter S (Chief Financial Officer) | Sale | 60,000 | 74.27 | 4,456,020 |
| 2021-08-23 | Garcia Peter S (Chief Financial Officer) | Option Ex | 60,000 | 4.08 | 244,800 |
| 2021-08-19 | Pons Jaume (President & CEO) | Sale | 16,700 | 63.06 | 1,053,035 |
| 2021-08-17 | Garcia Peter S (Chief Financial Officer) | Sale | 10,000 | 67.03 | 670,300 |
| 2021-08-17 | Garcia Peter S (Chief Financial Officer) | Option Ex | 10,000 | 4.08 | 40,800 |
| 2021-08-10 | Randolph Sophia (Chief Medical Officer) | Sale | 7,387 | 64.80 | 478,707 |
| 2021-07-19 | Pons Jaume (President & CEO) | Sale | 16,700 | 54.36 | 907,795 |
| 2021-07-12 | Randolph Sophia (Chief Medical Officer) | Sale | 7,387 | 55.36 | 408,922 |
| 2021-06-21 | Pons Jaume (President & CEO) | Sale | 16,700 | 58.49 | 976,766 |
| 2021-05-10 | Randolph Sophia (Chief Medical Officer) | Sale | 7,387 | 62.65 | 462,773 |
| 2021-04-19 | Pons Jaume (President & CEO) | Sale | 16,700 | 58.50 | 976,966 |
| 2021-04-12 | Randolph Sophia (Chief Medical Officer) | Sale | 7,387 | 60.52 | 447,053 |
| 2021-03-25 | Pons Jaume (President & CEO) | Option Ex | 10,000 | .99 | 9,900 |
| 2021-03-22 | Pons Jaume (President and CEO) | Sale | 16,700 | 67.21 | 1,122,340 |
| 2021-03-22 | Pons Jaume (President and CEO) | Option Ex | 16,700 | 1.91 | 31,897 |
| 2021-03-10 | Randolph Sophia (Chief Medical Officer) | Sale | 7,387 | 74.91 | 553,323 |
| 2021-01-28 | Garcia Peter S (Chief Financial Officer) | Option Ex | 6,128 | 4.08 | 25,002 |
| 2021-01-26 | Pons Jaume (President & CEO) | Option Ex | 10,000 | .99 | 9,900 |
| 2020-12-14 | Graham G. Walmsley (Director) | Buy | 20,000 | 76.00 | 1,520,000 |
| 2020-07-21 | Graham G. Walmsley (Director) | Buy | 975,000 | 19.00 | 18,525,000 |
| 2020-07-21 | Hemrajani Rekha (Director) | Buy | 3,000 | 19.00 | 57,000 |
| 2020-07-21 | Venbio Global Strategic Gp Ii, Ltd. | Buy | 853,000 | 19.00 | 16,207,000 |
| 2020-07-21 | Vivo Opportunity Fund, L.p. (10% Owner) | Buy | 975,000 | 19.00 | 18,525,000 |
| 2020-07-21 | Lettmann Jason (Director) | Buy | 400,000 | 19.00 | 7,600,000 |
| 2020-07-21 | Pietzke Steffen (VP Fin & Chief Acct Officer) | Buy | 3,000 | 19.00 | 57,000 |
| 2020-07-21 | Plain Henry A Jr (10% Owner) | Buy | 400,000 | 19.00 | 7,600,000 |
| 2020-07-21 | Goodman Corey S (Director) | Buy | 850,000 | 19.00 | 16,150,000 |
| 2020-07-21 | Garcia Peter S (Chief Financial Officer) | Buy | 3,000 | 19.00 | 57,000 |
Insider trading activities including stock purchases, stock sales, and option exercises of ALXO listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Alx Oncology Holdings Inc (symbol ALXO, CIK number 1810182) see the Securities and Exchange Commission (SEC) website.